Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care.

PLoS Medicine
Ramnath SubbaramanMadhukar Pai

Abstract

The cascade of care is a model for evaluating patient retention across sequential stages of care required to achieve a successful treatment outcome. This approach was first used to evaluate HIV care and has since been applied to other diseases. The tuberculosis (TB) community has only recently started using care cascade analyses to quantify gaps in quality of care. In this article, we describe methods for estimating gaps (patient losses) and steps (patients retained) in the care cascade for active TB disease. We highlight approaches for overcoming challenges in constructing the TB care cascade, which include difficulties in estimating the population-level burden of disease and the diagnostic gap due to the limited sensitivity of TB diagnostic tests. We also describe potential uses of this model for evaluating the impact of interventions to improve case finding, diagnosis, linkage to care, retention in care, and post-treatment monitoring of TB patients.

References

Apr 16, 2005·American Journal of Respiratory and Critical Care Medicine·Suzanne VerverPaul D van Helden
Dec 16, 2005·PLoS Medicine·Prabhat JhaUNKNOWN RGI-CGHR Prospective Study Collaborators
Aug 1, 2006·Bulletin of the World Health Organization·C KolappanP R Narayanan
Feb 6, 2008·BMJ : British Medical Journal·Helen S CoxPeter W Deutschmann
Jun 13, 2009·BMC Infectious Diseases·Chandrashekhar T SreeramareddyJ Van den Ende
Feb 4, 2010·The Journal of Infectious Diseases·Sujatha NarayananParanji Raman Narayanan
Jun 19, 2012·The Lancet Infectious Diseases·Aamir J KhanSalmaan Keshavjee
Aug 8, 2013·Transactions of the Royal Society of Tropical Medicine and Hygiene·Darshan MehraRajesh Kakkar
Oct 1, 2013·The Lancet Infectious Diseases·Bohdan NosykUNKNOWN STOP HIV/AIDS Study Group
Dec 25, 2013·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·R FatimaA Bassili
Jan 23, 2014·The Cochrane Database of Systematic Reviews·Karen R SteingartNandini Dendukuri
Mar 8, 2014·AIDS Patient Care and STDs·Brian C Zanoni, Kenneth H Mayer
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·C T SreeramareddyM Pai
May 3, 2014·BMJ : British Medical Journal·Anju Aggarwal
Sep 14, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·V K ChadhaP Kumar
Nov 8, 2014·Bulletin of the World Health Organization·Krycia CowlingLalit Dandona
Nov 18, 2014·Annals of Internal Medicine·Mohammed K AliCarlos Del Rio
Dec 30, 2014·The Lancet Global Health·Alimuddin ZumlaMatt Oliver
Mar 15, 2015·The Journal of Infectious Diseases·Madhukar Pai, Marco Schito
Mar 31, 2015·The Lancet. Respiratory Medicine·Anne K DetjenAnna M Mandalakas
Mar 31, 2015·Lancet·Mukund UplekarUNKNOWN for WHO's Global TB Programme
Jul 21, 2015·Infectious Disease Clinics of North America·Silvia S ChiangJeffrey R Starke
Aug 14, 2015·The Lancet Infectious Diseases·Jishnu DasMadhukar Pai
Sep 10, 2015·Current Opinion in HIV and AIDS·Kathryn RisherChris Beyrer
Nov 7, 2015·Current Opinion in HIV and AIDS·Noah HaberTill Bärnighausen
Mar 13, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A McDowell, M Pai
Oct 30, 2016·The Lancet Infectious Diseases·Nimalan ArinaminpathyPuneet Dewan
Oct 30, 2016·Transactions of the Royal Society of Tropical Medicine and Hygiene·Dina NairSoumya Swaminathan
Feb 23, 2017·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Michael J A Reid, Eric Goosby
Mar 13, 2017·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S PandeyN Arinaminpathy

❮ Previous
Next ❯

Citations

Jan 17, 2020·Gates Open Research·David J KedzioraRobyn M Stuart
May 24, 2020·The Journal of Applied Laboratory Medicine·Gyorgy Abel
Oct 6, 2020·Expert Review of Respiratory Medicine·Anurag BhargavaAnika Juneja
Dec 19, 2020·Revista brasileira de enfermagem·Nanci Michele SaitaAline Aparecida Monroe
Dec 12, 2020·International Journal for Equity in Health·Charity Oga-OmenkaChristina Zarowsky
Dec 22, 2020·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Jhon Edwin Polanco-PasajeFreddy Pérez
Feb 17, 2021·BMC Infectious Diseases·Helena R A FeaseyPeter MacPherson
Feb 18, 2021·Irish Journal of Medical Science·Conor GrantCatherine Fleming
Feb 25, 2021·Open Forum Infectious Diseases·Luis A RubioCarina Marquez
Mar 2, 2021·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Jhon Edwin Polanco-PasajeFreddy Pérez
Mar 16, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jeremiah ChakayaAlimuddin Zumla
Apr 4, 2021·International Journal of Environmental Research and Public Health·Laziz TuraevBarno Abdusamatova
Jun 8, 2021·The Cochrane Database of Systematic Reviews·Frederick HarakaAmanda Ross
Jul 13, 2021·Open Forum Infectious Diseases·Ramnath SubbaramanJessica E Haberer
Jun 18, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ignacio Monedero-RecueroFuad Mirzayev
Aug 20, 2021·Risk Management and Healthcare Policy·Sandul YasobantDeepak Saxena

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.